Literature DB >> 11869804

Expression and activity of nitric oxide synthase isoforms in rat brain during the development of experimental allergic encephalomyelitis.

Simone A Teixeira1, Gláucia M Castro, Fábio Papes, Maria L Martins, Fábio Rogério, Francesco Langone, Leonilda M B Santos, Paulo Arruda, Gilberto de Nucci, Marcelo N Muscará.   

Abstract

The activity and expression of nitric oxide synthase (NOS) isoforms and protein nitrotyrosine (NT) residues were investigated in whole encephalic mass (WEM) homogenates during the development of experimental allergic encephalomyelitis (EAE) in Lewis rats. EAE stages (0-III) were daily defined by clinical evaluation, and in the end of each stage, WEMs were removed for analysis of NOS activity, protein NT residues and mRNA for the different NOS isoforms. In the presence of NADPH, WEMs from EAE-III rats showed lower Ca2+-dependent NOS activity than those from control group. These differences disappeared in the presence of exogenous calmodulin, flavin adenine dinucleotide (FAD), tetrahydrobiopterin (BH4) and NADPH. Of all the cofactors, just the omission of FAD caused comparable decrease of Ca2+-dependent NOS activity from both groups. Ca2+-independent NOS activity from EAE-III animals was insensitive to the omission of any of the cofactors, while in control animals this activity was significantly inhibited by the omission of either FAD or BH4. Increased levels of both iNOS mRNA and protein NT expression were observed in animals with EAE, which also showed lower levels of a thermolabile NOS inhibitor in WEM homogenates and sera than controls. In conclusion, during late EAE stages, constitutive Ca2+-dependent NOS activity decreases concomitantly with iNOS upregulation, which could be responsible for the high protein NT levels. The differential dependence of iNOS activity on cofactors and the absence of an endogenous thermolabile NOS inhibitor in animals with EAE could reflect additional control mechanisms of NOS activity in this model of multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11869804     DOI: 10.1016/s0169-328x(01)00341-2

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  6 in total

1.  Local and cardiorenal effects of periodontitis in nitric oxide-deficient hypertensive rats.

Authors:  Bruno S Herrera; Rodrigo Martins-Porto; Paula Campi; Marinella Holzhausen; Simone A Teixeira; Gustavo D Mendes; Soraia K P Costa; Robert Gyurko; Thomas E Van Dyke; Luis C Spolidório; Marcelo N Muscará
Journal:  Arch Oral Biol       Date:  2010-09-22       Impact factor: 2.633

2.  Differing effects of exogenous and endogenous hydrogen sulphide in carrageenan-induced knee joint synovitis in the rat.

Authors:  E Ekundi-Valentim; K T Santos; E A Camargo; A Denadai-Souza; S A Teixeira; C I Zanoni; A D Grant; Jl Wallace; M N Muscará; S K Costa
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

3.  Endothelial NOS-deficient mice reveal dual roles for nitric oxide during experimental autoimmune encephalomyelitis.

Authors:  Muzhou Wu; Stella E Tsirka
Journal:  Glia       Date:  2009-08-15       Impact factor: 7.452

4.  Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: implication for X-adrenoleukodystrophy.

Authors:  Jaspreet Singh; Mushfiquddin Khan; Inderjit Singh
Journal:  J Lipid Res       Date:  2008-08-21       Impact factor: 5.922

5.  Sinomenine reduces iNOS expression via inhibiting the T-bet IFN-γ pathway in experimental autoimmune encephalomyelitis in rats.

Authors:  Bingjie Gu; Yanying Zeng; Cheng Yin; Huijiuan Wang; Xiaofan Yang; Song Wang; Xiaohui Ji
Journal:  J Biomed Res       Date:  2012-06-30

6.  Tempol ameliorates murine viral encephalomyelitis by preserving the blood-brain barrier, reducing viral load, and lessening inflammation.

Authors:  Maria Heloisa Tsuhako; Ohara Augusto; Edlaine Linares; Gerson Chadi; Selma Giorgio; Carlos A Pereira
Journal:  Free Radic Biol Med       Date:  2009-12-24       Impact factor: 7.376

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.